Skip to main content
SpringerLink
Log in

Journal Watch

  • Update
  • Published:
Pharmaceutical Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

Reference

  • Bonanno L, Favaretto A, Rugge M, et al. Role of genotyping in non-small cell lung cancer treatment: current status. Drugs 2011; 71 (17): 2231–46.

    Article  PubMed  CAS  Google Scholar 

Reference

  • Hershcovici T, Fass R. Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy. Drugs 2011; 71 (18): 2381–9.

    Article  PubMed  CAS  Google Scholar 

Reference

  • Wu L, Rosa-Neto P, Gauthier S. Use of biomarkers in clinical trials of Alzheimer disease: from concept to application. Mol Diag Ther 2011; 15 (6): 313–25.

    Article  CAS  Google Scholar 

Reference

Reference

  • Masi G, Brovedani P. The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression. CNS Drugs 2011; 25 (11): 913–31.

    Article  PubMed  CAS  Google Scholar 

Reference

  • Schultsz C, Geerlings, S. Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy. Drugs 2012; 72 (1): 1–16.

    Article  PubMed  CAS  Google Scholar 

Reference

  • Roerig JL, Steffen KJ, Mitchell JE. Atypical antipsychotic-induced weight gain: insights into mechanisms of action. CNS Drugs 2011; 25 (12): 1035–59.

    Article  PubMed  CAS  Google Scholar 

Reference

  • Arranz MJ, Rivera M, Munro JC. Pharmacogenetics of response to antipsychotics in patients with schizophrenia. CNS Drugs 2011; 25 (11): 933–69.

    Article  PubMed  CAS  Google Scholar 

Reference

  • Fagète S, Fischer N. Smarter drugs: a focus on pan-specific monoclonal antibodies. Biodrugs 2011; 25 (6): 357–64.

    Article  PubMed  Google Scholar 

Reference

  • Lum, LG, Thakur A. Targeting T cells with bispecific antibodies for cancer therapy. Biodrugs 2011; 25 (6): 365–79.

    Article  PubMed  CAS  Google Scholar 

Reference

  • Szodoray P, Alex P. Protein array diagnostics for guiding therapy in rheumatoid arthritis. Mol Diag Ther 2011; 15 (5): 247–54.

    Article  CAS  Google Scholar 

Reference

  • de la Monte SM. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer’s disease. Drugs 2012; 72 (1): 49–66.

    Article  PubMed  Google Scholar 

Reference

  • Shearer J, Green C, Ritchie CW, et al. Health state values for use in the economic evaluation of treatments for Alzheimer’s disease. Drugs Aging 2012; 29 (1): 31–43.

    Article  PubMed  Google Scholar 

Reference

  • Dams J, Bornschein B, Reese JP, et al. Modelling the cost effectiveness of treatments for Parkinson’s disease: a methodological review. Pharmacoeconomics 2011; 29 (12): 1025–49

    Article  PubMed  Google Scholar 

Reference

  • Layton D, Hazell L, Shakir SAW. Modified prescription-event monitoring studies: a tool for pharmacovigilance and risk management. Drug Saf 2011; 34 (12): e1–e9.

    Article  PubMed  Google Scholar 

Reference

  • Musteata FM. Calculation of normalized drug concentrations in the presence of altered plasma protein binding. Clin Pharmacokinet 2012; 51 (1): 55–68.

    Article  PubMed  CAS  Google Scholar 

Reference

  • Marouani H, Zografidis A, Iliadis A. Kinetic nomograms assist individualization of drug regimens. Clin Pharmacokinet 2011; 50 (12): 773–9.

    Article  PubMed  CAS  Google Scholar 

Reference

  • Ghobadi C, Johnson TN, Aarabi M, et al. Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance. Clin Pharmacokinet 2011; 50 (12): 809–22.

    Article  PubMed  CAS  Google Scholar 

Reference

  • Crijns I, Straus S, Luteijn M, et al. Implementation of the harmonized EU isotretinoin pregnancy prevention programme: a questionnaire survey among European regulatory agencies. Drug Saf 2012; 35 (1): 27–32.

    Article  PubMed  CAS  Google Scholar 

Reference

  • van Hunsel F, Härmark L, Pal S, et al. Experiences with adverse drug reaction reporting by patients: an 11-country survey. Drug Saf 2012; 35 (1): 45–60.

    Article  PubMed  Google Scholar 

Reference

  • Crooks CJ, Prieto-Merino D, Evans SJW. Identifying adverse events of vaccines using a Bayesian method of medically guided information sharing. Drug Saf 2012; 35 (1): 61–78.

    Article  PubMed  Google Scholar 

Reference

  • Tilling C, Krol M, Tsuchiya A, et al. Does the EQ-5D reflect lost earnings? Pharmacoeconomics 2012; 30 (1): 47–61.

    Article  PubMed  Google Scholar 

Reference

  • Jiang R, Jin Z, Liu Z, et al. Correlation of activated STAT3 expression with clinicopathologic features in lung adenocarcinoma and squamous cell carcinoma. Mol Diag Ther 2011; 15 (6): 347–52.

    Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Journal Watch. Pharm Med 26, 129–140 (2012). https://doi.org/10.1007/BF03256902

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03256902

Search

Navigation